Its a question that surfaces constantly in research forums, lab discussions, and private consultations
So two things to say about that
This is the long-term strategy, with less frequent injectionsmaybe weekly, monthly, or even every few months
Lorsbach BA, Sparks TC, Cicchillo RM, Garizi NV, Hahn DR, Meyer KG
Comparison Table of GLP-1 Treatments in the UK Which GLP-1 Is Best for Weight Loss Results
Review Article OPEN ACCESS Marko Duvnjak *,2,3 , Lucija Virovic-Jukic 1,4 , Davor Hrabar 1,4 and Lea Smircic Duvnjak 4,5 Author information Abstract Patients with nonalcoholic steatohepatitis (NASH) are at higher risk of progression to advanced stages of fibrosis, cirrhosis, hepatocellular carcinoma and other end-stage liver disease complications